Public recall detail

Limitations of test strips to check illegal drugs for dangerous substances

2023-04-17

medium
Recall Safety notice
Quick summary

Quick summary: Limitations of test strips to check illegal drugs for dangerous substances. Date: 2023-04-17.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Limitations of test strips to check illegal drugs for dangerous substances. Date: 2023-04-17.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand
ProductTest kits designed to detect illegal drugs
IssueHealth products - Product safety
IdentificationRA-73521

Affected products

ProductTest kits designed to detect illegal drugs
DescriptionIllegal drugs

Issue

With the growing availability of test strips on store shelves and online, Health Canada is reminding Canadians of the potential limitations of test strips to detect xylazine, fentanyl and other dangerous substances in illegal drugs. There are some test strips on the market designed to detect xylazine, fentanyl and some of its analogs (i.e. similar chemicals, such as carfentanil) in an individual's urine sample to determine whether they have taken the drug. Health Canada evaluates these to confirm their safety, quality and effectiveness and has authorized them for this specific use only. Others are used to detect xylazine, fentanyl and some of its analogs in substances that are, for example, seized by law enforcement. Testing strips for xylazine or fentanyl may also be sold directly to consumers. They are sold as consumer products and Health Canada does not review them for evidence of effectiveness as we do for medical devices. No test is 100 per cent effective at detecting all potentially dangerous substances in illegal drugs. A false negative could result in a fatal overdose. Treat all illegal drugs as though they are potentially contaminated with unknown and dangerous substances.

What you should do

  • Never consume alone.
  • Consider consuming a smaller dose: start low and go slow.
  • Don't mix opioids with alcohol or other drugs.
  • Go to a supervised consumption site if your community has one.
  • Carrynaloxone, which can temporarily reverse an opioid overdose. Make sure that you, and the people with you, know how to administer it.
  • Call 9-1-1 or your local emergency help line if you think someone is having a drug overdose.
  • Get your opioid overdose wallet card and carry it with you. Know what to do.
  • The test strips may only be able to detect certain substances, such as xylazine or fentanyl, and not other toxic substances that might be present, like carfentanil.
  • Illegal drugs can be mixed unevenly with other substances, so the portion tested may not contain the same amount of the drug as that which is to be consumed.
  • Other substances mixed in the sample could interfere with the accuracy of the test.
  • The sample size tested may be too limited to detect a specific substance.
  • Health Canada is advising Canadians of the potential limitations when using test strips to detect fentanyl (December 13, 2017)
  • Health Canada reminds Canadians of the limitations of fentanyl test strips being used to check street drugs before consumption
  • Signs of an Opioid Overdose
  • Naloxone
  • Canadian Pharmacists Association: Naloxone Made Easy (video)
Additional official information
AudienceGeneral public
CategoryHealth products - Drugs
CompaniesPublished by Health Canada
Published byHealth Canada
Alert / recall typePublic advisory
Identification numberRA-73521
Background{}
CompaniesPublished by Health Canada
AudiencesGeneral public
Source updated2023-04-17

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...